Treg cells from active RA patients with high disease activity (we have 42% RA patients with DAS-28 > 5.1) expressed elevated levels of SOCS1—a target of miR-155—which negatively regulates inflammatory processes. Here, SOCS1 is linked to rheumatoid arthritis.